proxygen is a biotech company based in vienna, austria, that systematically identifies molecular glue degraders – a completely new class of drugs.

this project entailed the full assembly of a cullin ring ligase complex from a total of four published protein datasets. The second and third images highlight a molecular glue molecule bringing it all together for targeted degradation.

colors of complex components strictly follow the proxygen corporate identity down to the grainy appearance of close-ups that closely match color gradients used on the proxygen website.